+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cell Counting Market Size, Share & Trends Analysis Report By Product (Instruments, Consumables & Accessories), By Application (Complete Blood Count, Stem Cell Research), By End-use, By Region, And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 120 Pages
  • September 2023
  • Region: Global
  • Grand View Research
  • ID: 4396470
The global cell counting market size is expected to reach USD 15.46 billion by 2030, expanding at a CAGR of 8.2% from 2023 to 2030. Rising prevalence of chronic diseases such as cancer, HIV, and Alzheimer’s is the high impact rendering growth driver of the industry. Increasing prevalence of these diseases has surged clinical research activities, consequently propelling the demand for cell counting instruments and consumables. Government initiatives working to promote the development of cell therapeutics, wherein cell counting plays an imperative role, are also expanding growth prospects for the market.

An increase in the number of collaborations of research institutes with various public and private entities to promote R&D has provided a significant boost to growth. Growing number of proposed guidelines and recommendations for public and private laboratories to ensure high-quality standards and facilitate the generation of accurate results are likely to improve the adoption of instruments over the coming years. For instance, in May 2021, the International Society for Stem Cell Research updated guidelines for the development of cell-based therapy and research. The proposed guidelines focus on all stages of R&D and improve the quality of preclinical studies.

Technological advancements in these devices are also broadening growth prospects of the market. One of the promising technological advancements in differential cell counting is the ability to recognize blasts, immunoplatelet counting, detection of blasts, and reticulocyte fractions and stem cell counting with greater accuracy. The advent of CD4+ T-cell counting technology has proven to be very useful as an indicator of immune responses and has been adopted to evaluate the success or failure of Anti-retroviral Therapy (ARV). Dedicated cytometers are present in the market to perform CD4+ and CD8+ T-cell enumeration, such as the FACSCount by Becton Dickinson is based on T-cell counting technology.

The COVID-19 pandemic is anticipated to positively impact industry growth. WBC count of the COVID-19 patient during admission is significantly correlated with the death of patients. A higher level of white blood count should be given further care in the COVID-19 treatment. The growing importance of cell count in patients suffering from COVID-19 has augmented the growth of the industry during the pandemic.

The development of enhanced informatics solutions and improved image analysis instruments such as optical or fluorescence microscopes have fueled the growth prospects of this market. These instruments are being increasingly adopted in low sample throughput laboratories and settings with limited resources, which is highly prevalent in developing economies, thereby broadening the scope for growth of the industry.

On the other hand, limited availability of skilled professionals is the critical growth-restraining factor of the market. The lack of skilled professionals can be attributed to a lack of training facilities and high training costs. In order to improve this scenario, industry players are required to participate in the generation of training programs for software developed by these companies and encourage healthcare professionals and researchers to operate cell counting software. Moreover, the lack of standardization of these software tools also plays a key role in restricting researchers and healthcare professionals as every software differ in user interface.

Cell Counting Market Report Highlights

  • By product, consumables and accessories segment accounted for the largest revenue share of 54.14% in 2022 and is expected to grow at the fastest CAGR of 8.4% over the forecast period
  • In the consumables and accessories segment, reagents held the largest revenue share of 56.3% in 2022. The large revenue share is attributed to the repeat purchase of these products for use during spectrophotometry, flow cytometry, and automated cell counting
  • The microplates sub-segment is poised to expand at the fastest CAGR during the forecast period. Microplates are usually used for analyzing very low concentration samples. The increased consumption of these plates is attributed to the repeated need to use fresh plates for analyzing a new sample to prevent contamination
  • In the instruments segment, automated cell counters are anticipated to grow at an exponential rate during the forecast period. Benefits such as short testing time, reduced error occurrence, and inter-operator variability are expected to further increase the demand for automated counters
  • By application, the complete blood count segment held the largest revenue share of 59.1% in 2022. The large revenue share can be attributed to increasing incidence of blood disorders
  • In the end-use segment, research and academic institutes accounted for the largest revenue share of 39.6% in2022 owing to growing number of government initiatives focused on promoting R&D in various toxicology studies
  • Pharmaceutical and biotechnology companies are anticipated to grow at the fastest CAGR of 9.0% during the forecast period
  • North America held the largest revenue share of over 37.6% owing to the increasing focus on biomedical and cancer research
  • Asia Pacific is expected to grow at the fastest CAGR of 10.3% over the forecast period owing to the large presence of clinical research organizations and biopharmaceutical companies in this region

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Application
1.1.3. End Use
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Application outlook
2.2.3. End-use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Cell Counting Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market Driver Analysis
3.4.2. Market Restraint Analysis
3.5. Cell Counting Market Analysis Tools
3.5.1. Industry Analysis - Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic Landscape
Chapter 4. Cell Counting Market: Product Type Estimates & Trend Analysis
4.1. Cell Counting Market: Key Takeaways
4.2. Cell Counting Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Instruments
4.3.1. Instruments market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.2. Spectrophotometers
4.3.2.1. Spectrophotometers market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.3. Flow cytometers
4.3.3.1. Flow cytometers market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.4. Hemocytometers
4.3.4.1. Hemocytometers market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.5. Automated cell counters
4.3.5.1. Automated cell counters market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.6. Microscopes
4.3.6.1. Microscopes market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.7. Others
4.3.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Consumable & Accessories
4.4.1.1. Consumable & Accessories market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.2. Reagents
4.4.2.1. Reagents market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.3. Microplates
4.4.3.1. Microplates market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.4. Others
4.4.4.1. Other market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Cell Counting Market: Application Estimates & Trend Analysis
5.1. Cell Counting Market: Key Takeaways
5.2. Cell Counting Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Complete Blood Count
5.3.1. Complete blood count market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Stem Cell Research
5.4.1. Stem cell research market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Cell-Based Therapeutics
5.5.1. Cell-based therapeutics market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Bioprocessing
5.6.1. Bioprocessing market estimates and forecasts, 2018 to 2030 (USD Million)
5.7. Toxicology
5.7.1. Toxicology market estimates and forecasts, 2018 to 2030 (USD Million)
5.8. Others
5.8.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Cell Counting Market: Regional Estimates & Trend Analysis
6.1. Regional Outlook
6.2. Cell Counting Market by Region: Key Marketplace Takeaway
6.3. North America
6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.3.2. U.S.
6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.3.3. Canada
6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4. Europe
6.4.1. U.K.
6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.2. Germany
6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.3. France
6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.4. Italy
6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.5. Spain
6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.6. Sweden
6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.7. Norway
6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.8. Denmark
6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5. Asia Pacific
6.5.1. Japan
6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.2. China
6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.3. India
6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.4. Australia
6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.5. Thailand
6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.6. South Korea
6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.6. Latin America
6.6.1. Brazil
6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.6.2. Mexico
6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.6.3. Argentina
6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.7. MEA
6.7.1. Saudi Arabia
6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.7.2. South Africa
6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.7.3. UAE
6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.7.4. Kuwait
6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Market Participant Categorization
7.2.1. ThermoFisher Scientific, Inc
7.2.1.1. Company overview
7.2.1.2. Financial performance
7.2.1.3. Product benchmarking
7.2.1.4. Strategic initiatives
7.2.2. Merck KGaA
7.2.2.1. Company overview
7.2.2.2. Financial performance
7.2.2.3. Product benchmarking
7.2.2.4. Strategic initiatives
7.2.3. Agilent Technologies
7.2.3.1. Company overview
7.2.3.2. Financial performance
7.2.3.3. Product benchmarking
7.2.3.4. Strategic initiatives
7.2.4. PerkinElmer, Inc
7.2.4.1. Company overview
7.2.4.2. Financial performance
7.2.4.3. Product benchmarking
7.2.4.4. Strategic initiatives
7.2.5. BD
7.2.5.1. Company overview
7.2.5.2. Financial performance
7.2.5.3. Product benchmarking
7.2.5.4. Strategic initiatives
7.2.6. Danaher
7.2.6.1. Company overview
7.2.6.2. Financial performance
7.2.6.3. Product benchmarking
7.2.6.4. Strategic initiatives
7.2.7. Bio-Rad Laboratories, Inc
7.2.7.1. Company overview
7.2.7.2. Financial performance
7.2.7.3. Product benchmarking
7.2.7.4. Strategic initiatives
7.2.8. BioTek Instruments, Inc
7.2.8.1. Company overview
7.2.8.2. Financial performance
7.2.8.3. Product benchmarking
7.2.8.4. Strategic initiatives
7.2.9. GE Healthcare
7.2.9.1. Company overview
7.2.9.2. Financial performance
7.2.9.3. Product benchmarking
7.2.9.4. Strategic initiatives
7.2.10. DeNovix Inc
7.2.10.1. Company overview
7.2.10.2. Financial performance
7.2.10.3. Product benchmarking
7.2.10.4. Strategic initiatives
List of Tables
Table 1 List of Abbreviations
Table 2 North America cell counting market, by product, 2018 - 2030 (USD Million)
Table 3 North America cell counting market, by application, 2018 - 2030 (USD Million)
Table 4 North America cell counting market, by end-use, 2018 - 2030 (USD Million)
Table 5 North America cell counting market, by region, 2018 - 2030 (USD Million)
Table 6 U.S. cell counting market, by product, 2018 - 2030 (USD Million)
Table 7 U.S. cell counting market, by application, 2018 - 2030 (USD Million)
Table 8 U.S. cell counting market, by end-use, 2018 - 2030 (USD Million)
Table 9 Canada cell counting market, by product, 2018 - 2030 (USD Million)
Table 10 Canada cell counting market, by application, 2018 - 2030 (USD Million)
Table 11 Canada cell counting market, by end-use, 2018 - 2030 (USD Million)
Table 12 Europe cell counting market, by product, 2018 - 2030 (USD Million)
Table 13 Europe cell counting market, by application, 2018 - 2030 (USD Million)
Table 14 Europe cell counting market, by end-use, 2018 - 2030 (USD Million)
Table 15 Europe cell counting market, by region, 2018 - 2030 (USD Million)
Table 16 Germany cell counting market, by product, 2018 - 2030 (USD Million)
Table 17 Germany cell counting market, by application, 2018 - 2030 (USD Million)
Table 18 Germany cell counting market, by end-use, 2018 - 2030 (USD Million)
Table 19 UK cell counting market, by product, 2018 - 2030 (USD Million)
Table 20 UK cell counting market, by application, 2018 - 2030 (USD Million)
Table 21 UK cell counting market, by end-use, 2018 - 2030 (USD Million)
Table 22 France cell counting market, by product, 2018 - 2030 (USD Million)
Table 23 France cell counting market, by application, 2018 - 2030 (USD Million)
Table 24 France cell counting market, by end-use, 2018 - 2030 (USD Million)
Table 25 Italy cell counting market, by product, 2018 - 2030 (USD Million)
Table 26 Italy cell counting market, by application, 2018 - 2030 (USD Million)
Table 27 Italy cell counting market, by end-use, 2018 - 2030 (USD Million)
Table 28 Spain cell counting market, by product, 2018 - 2030 (USD Million)
Table 29 Spain cell counting market, by application, 2018 - 2030 (USD Million)
Table 30 Spain cell counting market, by end-use, 2018 - 2030 (USD Million)
Table 31 Sweden cell counting market, by product, 2018 - 2030 (USD Million)
Table 32 Sweden cell counting market, by application, 2018 - 2030 (USD Million)
Table 33 Sweden cell counting market, by end-use, 2018 - 2030 (USD Million)
Table 34 Norway cell counting market, by product, 2018 - 2030 (USD Million)
Table 35 Norway cell counting market, by application, 2018 - 2030 (USD Million)
Table 36 Norway cell counting market, by end-use, 2018 - 2030 (USD Million)
Table 37 Denmark cell counting market, by product, 2018 - 2030 (USD Million)
Table 38 Denmark cell counting market, by application, 2018 - 2030 (USD Million)
Table 39 Denmark cell counting market, by end-use, 2018 - 2030 (USD Million)
Table 40 Asia Pacific cell counting market, by product, 2018 - 2030 (USD Million)
Table 41 Asia Pacific cell counting market, by application, 2018 - 2030 (USD Million)
Table 42 Asia Pacific cell counting market, by end-use, 2018 - 2030 (USD Million)
Table 43 Asia Pacific cell counting market, by region, 2018 - 2030 (USD Million)
Table 44 China cell counting market, by product, 2018 - 2030 (USD Million)
Table 45 China cell counting market, by application, 2018 - 2030 (USD Million)
Table 46 China cell counting market, by end-use, 2018 - 2030 (USD Million)
Table 47 Japan cell counting market, by product, 2018 - 2030 (USD Million)
Table 48 Japan cell counting market, by application, 2018 - 2030 (USD Million)
Table 49 Japan cell counting market, by end-use, 2018 - 2030 (USD Million)
Table 50 India cell counting market, by product, 2018 - 2030 (USD Million)
Table 51 India cell counting market, by application, 2018 - 2030 (USD Million)
Table 52 India cell counting market, by end-use, 2018 - 2030 (USD Million)
Table 53 Thailand cell counting market, by product, 2018 - 2030 (USD Million)
Table 54 Thailand cell counting market, by application, 2018 - 2030 (USD Million)
Table 55 Thailand cell counting market, by end-use, 2018 - 2030 (USD Million)
Table 56 South Korea cell counting market, by product, 2018 - 2030 (USD Million)
Table 57 South Korea cell counting market, by application, 2018 - 2030 (USD Million)
Table 58 South Korea cell counting market, by end-use, 2018 - 2030 (USD Million)
Table 59 Latin America cell counting market, by product, 2018 - 2030 (USD Million)
Table 60 Latin America cell counting market, by application, 2018 - 2030 (USD Million)
Table 61 Latin America cell counting market, by end-use, 2018 - 2030 (USD Million)
Table 62 Latin America cell counting market, by region, 2018 - 2030 (USD Million)
Table 63 Brazil cell counting market, by product, 2018 - 2030 (USD Million)
Table 64 Brazil cell counting market, by application, 2018 - 2030 (USD Million)
Table 65 Brazil cell counting market, by end-use, 2018 - 2030 (USD Million)
Table 66 Mexico cell counting market, by product, 2018 - 2030 (USD Million)
Table 67 Mexico cell counting market, by application, 2018 - 2030 (USD Million)
Table 68 Mexico cell counting market, by end-use, 2018 - 2030 (USD Million)
Table 69 Argentina cell counting market, by product, 2018 - 2030 (USD Million)
Table 70 Argentina cell counting market, by application, 2018 - 2030 (USD Million)
Table 71 Argentina cell counting market, by end-use, 2018 - 2030 (USD Million)
Table 72 Middle East and Africa cell counting market, by product, 2018 - 2030 (USD Million)
Table 73 Middle East and Africa cell counting market, by application, 2018 - 2030 (USD Million)
Table 74 Middle East and Africa cell counting market, by end-use, 2018 - 2030 (USD Million)
Table 75 Middle East and Africa cell counting market, by region, 2018 - 2030 (USD Million)
Table 76 South Africa cell counting market, by product, 2018 - 2030 (USD Million)
Table 77 South Africa cell counting market, by application, 2018 - 2030 (USD Million)
Table 78 South Africa cell counting market, by end-use, 2018 - 2030 (USD Million)
Table 79 Saudi Arabia cell counting market, by product, 2018 - 2030 (USD Million)
Table 80 Saudi Arabia cell counting market, by application, 2018 - 2030 (USD Million)
Table 81 Saudi Arabia cell counting market, by end-use, 2018 - 2030 (USD Million)
Table 82 UAE cell counting market, by product, 2018 - 2030 (USD Million)
Table 83 UAE cell counting market, by application, 2018 - 2030 (USD Million)
Table 84 UAE cell counting market, by end-use, 2018 - 2030 (USD Million)
Table 85 Kuwait cell counting market, by product, 2018 - 2030 (USD Million)
Table 86 Kuwait cell counting market, by application, 2018 - 2030 (USD Million)
Table 87 Kuwait cell counting market, by end-use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Cell counting: Market outlook
Fig. 9 Cell counting: Competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Cell counting market driver impact
Fig. 15 Cell counting market restraint impact
Fig. 16 Cell counting market strategic initiatives analysis
Fig. 17 Cell counting market: Product type movement analysis
Fig. 18 Cell counting market: Product type outlook and key takeaways
Fig. 19 Instruments market estimates and forecasts, 2018 - 2030
Fig. 20 Consumables & accessories market estimates and forecasts, 2018 - 2030
Fig. 21 Cell counting market: Application movement analysis
Fig. 22 Cell counting market: Application outlook and key takeaways
Fig. 23 Complete blood count market estimates and forecasts, 2018 - 2030
Fig. 24 Stem cell research market estimates and forecasts, 2018 - 2030
Fig. 25 Cell-based therapeutics market estimates and forecasts, 2018 - 2030
Fig. 26 Bioprocessing market estimates and forecasts, 2018 - 2030
Fig. 27 Toxicology market estimates and forecasts, 2018 - 2030
Fig. 28 Others market estimates and forecasts, 2018 - 2030
Fig. 29 Cell counting market: End-use movement analysis
Fig. 30 Cell counting market: End-use outlook and key takeaways
Fig. 31 Hospitals & diagnostic laboratories market estimates and forecasts, 2018 - 2030
Fig. 32 Research & academic Institutes market estimates and forecasts, 2018 - 2030
Fig. 33 Pharmaceutical & biotechnology companies market estimates and forecasts, 2018 - 2030
Fig. 34 Others market estimates and forecasts, 2018 - 2030
Fig. 35 Global cell counting market: Regional movement analysis
Fig. 36 Global cell counting market: Regional outlook and key takeaways
Fig. 37 North America market estimates and forecasts, 2018 - 2030
Fig. 38 U.S. market estimates and forecasts, 2018 - 2030
Fig. 39 Canada market estimates and forecasts, 2018 - 2030
Fig. 40 Europe. market estimates and forecasts, 2018 - 2030
Fig. 41 U.K. market estimates and forecasts, 2018 - 2030
Fig. 42 Germany market estimates and forecasts, 2018 - 2030
Fig. 43 France market estimates and forecasts, 2018 - 2030
Fig. 44 Italy market estimates and forecasts, 2018 - 2030
Fig. 45 Spain market estimates and forecasts, 2018 - 2030
Fig. 46 Sweden market estimates and forecasts, 2018 - 2030
Fig. 47 Norway market estimates and forecasts, 2018 - 2030
Fig. 48 Denmark market estimates and forecasts, 2018 - 2030
Fig. 49 Asia Pacific market estimates and forecasts, 2018 - 2030
Fig. 50 Japan market estimates and forecasts, 2018 - 2030
Fig. 51 China market estimates and forecasts, 2018 - 2030
Fig. 52 India market estimates and forecasts, 2018 - 2030
Fig. 53 Australia market estimates and forecasts, 2018 - 2030
Fig. 54 Thailand market estimates and forecasts, 2018 - 2030
Fig. 55 South Korea market estimates and forecasts, 2018 - 2030
Fig. 56 Latin America market estimates and forecasts, 2018 - 2030
Fig. 57 Brazil market estimates and forecasts, 2018 - 2030
Fig. 58 Mexico market estimates and forecasts, 2018 - 2030
Fig. 59 Argentina market estimates and forecasts, 2018 - 2030
Fig. 60 Middle East and Africa. market estimates and forecasts, 2018 - 2030
Fig. 61 Saudi Arabia market estimates and forecasts, 2018 - 2030
Fig. 62 South Africa market estimates and forecasts, 2018 - 2030
Fig. 63 UAE market estimates and forecasts, 2018 - 2030
Fig. 64 Kuwait market estimates and forecasts, 2018 - 2030

Companies Mentioned

  • ThermoFisher Scientific, Inc
  • Merck KGaA
  • Agilent Technologies
  • PerkinElmer, Inc
  • BD
  • Danaher
  • Bio-Rad Laboratories, Inc
  • BioTek Instruments, Inc
  • GE Healthcare
  • DeNovix Inc

Methodology

Loading
LOADING...

Table Information